Backs FY24 adjusted EBITDA view up 50%. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on TMCI: Treace to Report Second Quarter 2024 Financial Results on August 6, 2024 Treace Medical price target raised to $9 from $7 at Truist Treace Medical price target raised to $8 from $5.50 at Morgan Stanley Questions or Comments about the article? Write to editor@tipranks.com